Page last updated: 2024-09-05

sdz mks 492 and Asthma, Bronchial

sdz mks 492 has been researched along with Asthma, Bronchial in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardin, PG; Dorward, MA; Franke, B; Holgate, ST; Lampe, FC1
Chapman, ID; Mazzoni, L; Morley, J1

Trials

1 trial(s) available for sdz mks 492 and Asthma, Bronchial

ArticleYear
Effect of selective phosphodiesterase 3 inhibition on the early and late asthmatic responses to inhaled allergen.
    British journal of clinical pharmacology, 1998, Volume: 45, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adolescent; Adult; Allergens; Asthma; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Female; Forced Expiratory Volume; Humans; Inhalation Exposure; Male; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Purinones

1998

Other Studies

1 other study(ies) available for sdz mks 492 and Asthma, Bronchial

ArticleYear
SDZ MKS 492.
    Agents and actions. Supplements, 1991, Volume: 34

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Guinea Pigs; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Purinones; Respiratory Hypersensitivity; Respiratory System; Trachea

1991